Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients. - Wikidata - awgldk - TriplyDB

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

http://www.wikidata.org/entity/Q42464003

about

Imaging tumor metabolism using positron emission tomography Positron emission tomography of high-grade gliomas.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and Histopathology Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.In search of druggable targets for GBM amino acid metabolism.Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.Amino acid PET and MR perfusion imaging in brain tumours.Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis.PET/CT imaging of the diapeutic alkylphosphocholine analog 124I-CLR1404 in high and low-grade brain tumors.Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.11C-Methionine positron emission tomography delineates non-contrast enhancing tumor regions at high risk for recurrence in pediatric high-grade glioma.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors.18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.

P2860

Q28085278-53A9B15D-6BCD-4F2D-8A24-E63999AB8BE9 Q31047940-5ECDC280-CAA7-4C7A-9926-1673DD97E437 Q35679377-FA0E0F67-5621-49BE-B9F9-9F5D975AF92F Q35821500-18FFC2E2-FA05-4591-874C-99F1089A0D05 Q35927273-3B0D5E7E-FF84-4B30-B3C3-479C8023EE61 Q36293108-BD7B1DA0-D699-413E-928D-E5EBD6FAE151 Q38656133-B08AE31C-6D20-4603-B0EE-674020C9EF8B Q38691946-594C9791-F7AF-4F9E-9440-E860F559B644 Q39031636-2B2A9E89-D532-4542-9E43-4791A5E87CC0 Q40333907-3BD7E0A6-C6FA-410E-9A81-73D97531CF87 Q41180726-FE7840F8-6038-40E5-84FF-7180FE6015EE Q41594601-0915D2E4-1284-4D5C-BBCF-98E2B6A851B6 Q42489454-A5F6DEB6-932B-47D1-B366-61E8D3A246ED Q42545669-0A45067B-99B0-4870-AF72-4BC6E99B3F3A Q45050601-5F0FD0D0-F82F-421F-BA8B-334C9D1C72DA Q48158155-6D56612F-7C0F-442A-83FA-097605A83CB7 Q52801683-BED1A815-C4CE-49F6-A972-45268E893E17 Q54135407-54773A06-349C-4F99-9B94-0EF6333116A3

P2860

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

http://www.wikidata.org/entity/Q42464003

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

@en

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

@nl

type

label

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

@en

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

@nl

prefLabel

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

@en

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

@nl

P1433

Q42464003-FAF64360-7D7F-45E1-9107-C2EE733D987D

P1476

Q42464003-57604CDE-B919-4E01-8891-D6C819A79862

P2093

Q42464003-23C27847-BA50-402C-B18A-8858AEA1513B

Q42464003-45137D07-D1B9-4BCD-A5F9-5DE459FAFD99

Q42464003-47A3E562-800B-4F73-BDB5-40D0ABAB30B2

Q42464003-4914672E-DA06-4A5D-A829-CC7BA1F74840

Q42464003-5CF9DCF4-19F9-4EAE-80CE-7BC54ECB71FF

Q42464003-88173CFB-FE29-4289-90EC-36DE5303A965

Q42464003-C3C957D1-BC5B-4163-A8E6-A1C49C72D615

Q42464003-C5B200A4-6F36-408F-9D89-82AAB9A9E992

Q42464003-CE3036BC-FBBE-463A-BE26-340C6DE00791

Q42464003-D1AAEE54-3B36-4745-B35A-CD4BDEDFDF6C

P304

Q42464003-CB4B0027-9801-445E-8A0E-78C482052D1D

P31

Q42464003-4BA59548-9C21-4FB7-9F0B-A90FEE4F32C1

P356

Q42464003-695A9177-2512-4658-A7A6-AB090F0E840E

P407

Q42464003-95D3CE3E-FF15-4D4F-A67C-B4F304F3D068

P433

Q42464003-E8C2DE15-2845-4609-9615-E515C757F7DD

P478

Q42464003-5A6348A5-8131-4C01-B3EA-982B6A304B23

P50

Q42464003-6A4217CC-6B14-44A2-94A8-39520875BE8B

Q42464003-78E42BB8-64C1-4F49-9547-01FA623ED0F4

P577

Q42464003-2602C846-8F22-4E55-BFE8-2ACC6D7E7266

P5875

Q42464003-859F933F-6767-4573-9F3B-464FE89FAA9F

P698

Q42464003-F630833C-1690-4B2B-955F-F96563F8B6A3

P356

JNUMED.114.140608

P1433

The Journal of Nuclear Medicine

P1476

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

@en

P2093

Almuth F Kessler

http://www.w3.org/2001/XMLSchema#string

Camelia Maria Monoranu

http://www.w3.org/2001/XMLSchema#string

Christina Bluemel

http://www.w3.org/2001/XMLSchema#string

Constantin Lapa

http://www.w3.org/2001/XMLSchema#string

Gyoergy A Homola

http://www.w3.org/2001/XMLSchema#string

Johannes Czernin

http://www.w3.org/2001/XMLSchema#string

Ken Herrmann

http://www.w3.org/2001/XMLSchema#string

Mario Löhr

http://www.w3.org/2001/XMLSchema#string

Ralf-Ingo Ernestus

http://www.w3.org/2001/XMLSchema#string

Samuel Samnick

http://www.w3.org/2001/XMLSchema#string

P304

1611-1616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.114.140608

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Andreas K. Buck

Thomas Linsenmann

P577

2014-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264833176

http://www.w3.org/2001/XMLSchema#string

P698

25125481

http://www.w3.org/2001/XMLSchema#string